SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Anil R. Diwan, PhD, President and Executive Chairman of the Company will provide an update on the Company, its Drug Pipeline and Platform Technologies available for licensing. NanoViricides’ Current ...
Over 90% of human pathogenic viruses use heparan sulfate features, which NV-387 copies and presents to fool the virus. NV-387 is designed to attack the virus particle and destroy it by fooling the ...
(Refiles to include words missing from headline) KINSHASA, Dec 1 (Reuters) - An Ebola outbreak in the Democratic Republic of ...
KINSHASA, Congo -- Congo announced the end of the country's 16th Ebola outbreak on Monday. “To date, the DRC has 53 confirmed ...
MONDAY, Nov. 17, 2025 (HealthDay News) — At least nine people in southern Ethiopia have been infected with Marburg virus, a ...
At least nine people in Ethiopia have been infected with Marburg virus, a deadly illness similar to Ebola, the World Health Organization said.
Dr. Summa Bibby from UQ's School of Chemistry and Molecular Bioscience said despite decades of research on yellow fever, this was the first time a complete 3D structure of a fully mature yellow fever ...
Trump aid cuts could push next Ebola outbreak to spiral out of control, former US official warns - A countdown is on to ...
For years scientists have suspected that the Epstein-Barr virus (EBV)—a type of herpesvirus that infects 94 percent of the global population by adulthood and causes mononucleosis (aka “mono”)—might be ...
This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results